Get highlights of two studies that provide insight into why some women with early-stage breast cancer choose to have a double mastectomy and the risk of complications they may experience after this surgery.
Many kids have been away from school for the summer, but what about if you’ve been away for cancer treatment? Find out what steps you can take to make the return to the classroom a little smoother.
In these podcasts, Cancer.Net experts provide context for some of the science highlights from the 2014 ASCO Annual Meeting earlier this year.
Research Round Up podcasts series continues! Two more expert-led podcasts with highlights from ASCO’s Annual Meeting on brain tumors, central nervous system tumors, and childhood cancers.
Two expert-led podcasts with highlights from ASCO’s Annual Meeting. These podcasts cover research on prostate cancer, bladder cancer, and melanoma.
You probably heard a lot of research buzz during ASCO’s recent Annual Meeting. But as the dust settles, we’ll continue to highlight some of the important research that was presented at the meeting. Over the next several weeks, the Research Round Up podcast series will feature top cancer experts explaining what this research means for patients.
High temperatures can cause issues for people receiving cancer treatment. Get some tips on staying cool and hydrated this summer.
In this podcast, two oncology pharmacists share about their role on the cancer care team. Hear from experts R. Donald Harvey, PharmD, FCCP, BCOP and John Valgus, PharmD, BCOP, CPP.
Research Highlights on Immunotherapy for Melanoma and Cervical Cancer From the 2014 ASCO Annual Meeting
Activating and amplifying the body’s immune response to cancer is an exciting area of research. See how it is being used to better treat advanced or high-risk melanoma and cervical cancer in these four studies presented in Chicago today.
Get highlights of four pivotal studies that reveal new ways to optimize commonly used chemotherapy, hormone therapy, and newer targeted drugs, and answer critical questions about the effectiveness of two common treatment regimens for advanced colorectal cancer.